MedPage Today on MSN

Rare childhood disorder gets its first FDA drug approval

The FDA approved copper histidinate (Zycubo) as the first treatment for Menkes disease in pediatric patients, the agency ...
Medscape

FDA Approves First Treatment for Menkes Disease in Children

The FDA has approved Zycubo (copper histidinate) injection as the first and only treatment of Menkes disease in pediatric patients.

US FDA approves Fortress Bio and Zydus' treatment for a rare pediatric disease

The U.S. Food and Drug Administration approved Fortress Biotech and Indian drugmaker Zydus Lifesciences' drug ​for children ...

FDA Approves First At-Home Brain Stimulation Device For Depression

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...
New Atlas

First US at-home depression kit on its way after trial shows relief in weeks

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...

FDA approves first treatment for rare blood disorder in pediatric patients 12 and older

The treatment for acquired thrombotic thrombocytopenic purpura, a rare blood disorder that causes blood clots in the small ...